Hims & Hers Health (HIMS) Net Cash Flow (QoQ) (2019 - 2026)
Hims & Hers Health (HIMS) Net Cash Flow (QoQ) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn |
| 10 | Hims & Hers Health | 6.44 Bn | 5.69 Bn | 396.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 96.69% |
| Dec 31, 2025 | 84.58% |
| Sep 30, 2025 | -191.60% |
| Jun 30, 2025 | 1,493.52% |
| Mar 31, 2025 | -4.05% |
| Dec 31, 2024 | 54.10% |
| Sep 30, 2024 | 49.77% |
| Jun 30, 2024 | 180.67% |
| Mar 31, 2024 | -77.86% |
| Dec 31, 2023 | 621.13% |
| Sep 30, 2023 | -144.60% |
| Jun 30, 2023 | 750.77% |
| Mar 31, 2023 | 117.52% |
| Dec 31, 2022 | -483.36% |
| Sep 30, 2022 | -56.99% |
| Jun 30, 2022 | 128.87% |
| Mar 31, 2022 | -432.58% |
| Dec 31, 2021 | 116.66% |
| Sep 30, 2021 | -323.01% |
| Jun 30, 2021 | -68.69% |